» Articles » PMID: 10027411

Oval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1999 Feb 23
PMID 10027411
Citations 158
Authors
Affiliations
Soon will be listed here.
Abstract

The risk of developing hepatocellular carcinoma is significantly increased in patients with genetic hemochromatosis, alcoholic liver disease, or chronic hepatitis C infection. The precise mechanisms underlying the development of hepatocellular carcinoma in these conditions are not well understood. Stem cells within the liver, termed oval cells, are involved in the pathogenesis of hepatocellular carcinoma in animal models and may be important in the development of hepatocellular carcinoma in human chronic liver diseases. The aims of this study were to determine whether oval cells could be detected in the liver of patients with genetic hemochromatosis, alcoholic liver disease, or chronic hepatitis C, and whether there is a relationship between the severity of the liver disease and the number of oval cells. Oval cells were detected using histology and immunohistochemistry in liver biopsies from patients with genetic hemochromatosis, alcoholic liver disease, or chronic hepatitis C. Oval cells were not observed in normal liver controls. Oval cell numbers increased significantly with the progression of disease severity from mild to severe in each of the diseases studied. We conclude that oval cells are frequently found in subjects with genetic hemochromatosis, alcoholic liver disease, or chronic hepatitis C. There is an association between severity of liver disease and increase in the number of oval cells consistent with the hypothesis that oval cell proliferation is associated with increased risk for development of hepatocellular carcinoma in chronic liver disease.

Citing Articles

RAGE is a key regulator of ductular reaction-mediated fibrosis during cholestasis.

Lam W, Gabernet G, Poth T, Sator-Schmitt M, Oquendo M, Kast B EMBO Rep. 2025; 26(3):880-907.

PMID: 39747668 PMC: 11811172. DOI: 10.1038/s44319-024-00356-7.


Overview of hepatocarcinogenesis focusing on cellular origins of liver cancer stem cells: a narrative review.

Eun J J Yeungnam Med Sci. 2024; 42:3.

PMID: 39523770 PMC: 11812091. DOI: 10.12701/jyms.2024.01088.


"Small Hepatocytes" in the Liver.

Mitaka T, Ichinohe N, Tanimizu N Cells. 2023; 12(23).

PMID: 38067145 PMC: 10705974. DOI: 10.3390/cells12232718.


VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis.

Rizvi F, Lee Y, Diaz-Aragon R, Bawa P, So J, Florentino R Cell Stem Cell. 2023; 30(12):1640-1657.e8.

PMID: 38029740 PMC: 10843608. DOI: 10.1016/j.stem.2023.10.008.


Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment.

Iakovleva V, Wuestefeld A, Ong A, Gao R, Kaya N, Lee M NPJ Regen Med. 2023; 8(1):63.

PMID: 37935709 PMC: 10630300. DOI: 10.1038/s41536-023-00337-9.


References
1.
MacSween R, Scott A . Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Pathol. 1973; 26(12):936-42. PMC: 477934. DOI: 10.1136/jcp.26.12.936. View

2.
Olynyk J, Yeoh G, Ramm G, Clarke S, Hall P, Britton R . Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction. Am J Pathol. 1998; 152(2):347-52. PMC: 1857969. View

3.
Evarts R, Nagy P, Marsden E, Thorgeirsson S . A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis. 1987; 8(11):1737-40. DOI: 10.1093/carcin/8.11.1737. View

4.
Sell S, Dunsford H . Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol. 1989; 134(6):1347-63. PMC: 1879951. View

5.
Colombo M, Kuo G, Choo Q, Donato M, Del Ninno E, Tommasini M . Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989; 2(8670):1006-8. DOI: 10.1016/s0140-6736(89)91016-7. View